Hematopoietic/erythropoietic differentiation of human embryonic stem cells

人胚胎干细胞的造血/红细胞分化

基本信息

  • 批准号:
    7892600
  • 负责人:
  • 金额:
    $ 12.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal is designed to provide the Principal Investigator, Kai-Hsin Chang, with a training experience in the fields of molecular biology to expand the characterization of the commitment and differentiation of hematopoietic/erythroid cells from human embryonic stem cells (hESCs) and to study the expression of beta- locus globin genes at both cellular and molecular levels. The proposed studies are based on the observation that while hESCs can be induced to undergo hematopoietic and erythroid differentiation to help delineate the mechanisms underlying early events of hematopoiesis, the efficiency of generating hematopoietic/erythroid progenitors is low. Furthermore, unlike their fetal liver counterparts that mainly express fetal gamma globin, hESC-derived fetal-like definitive erythroid cells coexpress high levels of embryonic (epsilon) and fetal (gamma) globins with little adult beta globin. Thus, hESC-derived erythroid cells represent a valuable tool to study the activation and silencing of the beta-locus globin genes. The following specific aims are proposed: 1) To study the effect of ectopic expression of homeobox (Hox) transcription factor HoxB4 on the hematopoietic/erythroid differentiation of hESCs. 2) To characterize the cis- and trans-acting elements associated with the unique beta-locus globin expression pattern of hESC-derived erythroid cells. 3) To study the modulation of beta-locus globin gene expression by manipulation of intracellular transcriptional environment via cell fusion. While the applicant's short-term goal is to learn the molecular techniques to investigate hematopoietic/erythropoietic differentiation of hESCs and to study the regulatory mechanisms governing the globin expression. Her long-term goal is to develop an independent research program devoted to the study of erythroid cells, which will contribute to the development of althernative therapy for treating hemoglobinpathies. Dr. Thalia Papayannopoulou's laboratory has an outstanding record of studying the globin regulation using cellular and molecular approaches and thus will provide the applicant with an appropriate and stimulating teaching environment. The applicant will also benefit from the expertise of several other investigators nearby, including Dr. George Stamatoyannopoulos, the co-mentor, and Drs. David Russell, and Xiangdong Fang, the advisory committee members, necessary to accomplish the goal of present application and future objectives.
描述(由申请人提供): 该提案旨在为主要研究者Kai-Hsin Chang提供分子生物学领域的培训经验,以扩展人胚胎干细胞(hESC)造血/红系细胞定型和分化的表征,并研究β-位点珠蛋白基因在细胞和分子水平上的表达。提出的研究是基于这样的观察,即虽然hESC可以被诱导经历造血和红细胞分化以帮助描述造血早期事件的潜在机制,但产生造血/红细胞祖细胞的效率很低。此外,与主要表达胎儿γ球蛋白的胎儿肝对应物不同,hESC衍生的胎儿样定形红系细胞共表达高水平的胚胎(γ)和胎儿(γ)球蛋白,几乎没有成人β球蛋白。因此,hESC衍生的红系细胞代表了研究β基因座珠蛋白基因的激活和沉默的有价值的工具。本研究的具体目的如下:1)研究同源异型盒(homeobox,Hox)转录因子HoxB4的异位表达对hESC造血/红系分化的影响。2)表征与hESC衍生的红系细胞的独特β位点珠蛋白表达模式相关的顺式和反式作用元件。3)研究通过细胞融合调控细胞内转录环境对β位点珠蛋白基因表达的调控。而申请人的短期目标是学习分子技术来研究hESCs的造血/红细胞生成分化,并研究控制球蛋白表达的调节机制。她的长期目标是开发一个独立的研究计划,致力于红系细胞的研究,这将有助于开发治疗血红蛋白病的替代疗法。Thalia Papayannopoulou博士的实验室在使用细胞和分子方法研究珠蛋白调节方面有着出色的记录,因此将为申请人提供适当和刺激的教学环境。申请人还将受益于附近其他几位研究者的专业知识,包括共同导师乔治斯塔马托扬诺普洛斯博士和顾问委员会成员大卫罗素博士和方向东博士,这些都是实现当前申请目标和未来目标所必需的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kai-Hsin Chang其他文献

Kai-Hsin Chang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kai-Hsin Chang', 18)}}的其他基金

Hematopoietic/erythropoietic differentiation of human embryonic stem cells
人胚胎干细胞的造血/红细胞分化
  • 批准号:
    7985264
  • 财政年份:
    2009
  • 资助金额:
    $ 12.71万
  • 项目类别:
Hematopoietic/erythropoietic differentiation of human embryonic stem cells
人胚胎干细胞的造血/红细胞分化
  • 批准号:
    7244902
  • 财政年份:
    2007
  • 资助金额:
    $ 12.71万
  • 项目类别:
Hematopoietic/erythropoietic differentiation of human embryonic stem cells
人胚胎干细胞的造血/红细胞分化
  • 批准号:
    7590480
  • 财政年份:
    2007
  • 资助金额:
    $ 12.71万
  • 项目类别:
Hematopoietic/erythropoietic differentiation of human embryonic stem cells
人胚胎干细胞的造血/红细胞分化
  • 批准号:
    8058798
  • 财政年份:
    2007
  • 资助金额:
    $ 12.71万
  • 项目类别:
Hematopoietic/erythropoietic differentiation of human embryonic stem cells
人胚胎干细胞的造血/红细胞分化
  • 批准号:
    7364566
  • 财政年份:
    2007
  • 资助金额:
    $ 12.71万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 12.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了